Get the Stockscreener App
0.2302
5.07%
-0.0123
After Hours:
.23
-0.0002
-0.09%
Liminatus Pharma Inc stock is traded at $0.2302, with a volume of 1.46M.
It is down -5.07% in the last 24 hours and down -78.49% over the past month.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
See More
Previous Close:
$0.2425
Open:
$0.2491
24h Volume:
1.46M
Relative Volume:
0.20
Market Cap:
$9.05M
Revenue:
-
Net Income/Loss:
$-1.40M
P/E Ratio:
-1.1099
EPS:
-0.2074
Net Cash Flow:
$-10.49M
1W Performance:
-0.90%
1M Performance:
-78.49%
6M Performance:
-92.28%
1Y Performance:
+0.00%
1-Day Range:
$0.21
$0.2538
1-Week Range:
$0.21
$0.2747
52-Week Range:
$0.21
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Name
Liminatus Pharma Inc
Sector
Industry
Phone
213-273-5453
Address
6 CENTERPOINTE DR., LA PALMA
Compare LIMN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.2302 | 9.54M | 0 | -1.40M | -10.49M | -0.2074 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.27 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.66 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.11 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.65 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.02 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
Liminatus Pharma Inc Stock (LIMN) Latest News
Critical Analysis: Liminatus Pharma (NASDAQ:LIMN) and Athira Pharma (NASDAQ:LONA) - Defense World
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation - The Ames Tribune
Market Review: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestJuly 2025 Catalysts & Safe Entry Zone Tips - baoquankhu1.vn
Aug EndMonth: What are Liminatus Pharma Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Earnings Risk: What are Liminatus Pharma Incs recent SEC filings showing2025 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Can Liminatus Pharma Inc. Equity Warrant stock deliver strong Q4 earnings2025 Historical Comparison & AI Forecast Swing Trade Picks - mfd.ru
Trend Recap: What is QSIAWs valuation compared to sectorProfit Target & High Conviction Investment Ideas - baoquankhu1.vn
Liminatus Pharma Completes $4 Million Public Equity Offering - TipRanks
Liminatus Pharma Prices $0.29 Equity Offering, Nets $3.46 Million Under Securities Purchase Pact - TradingView
Aug Highlights: Can Liminatus Pharma Inc Equity Warrant be recession proofJuly 2025 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
Liminatus Pharma prices $4 million public offering at $0.29 per share - Investing.com India
Liminatus Pharma prices 13.8M shares at 29c in public offering - TipRanks
Gold Down 3%; Medtronic Earnings Top Views - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering - Bitget
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
Bond Watch: What dividend growth rate does Sun Communities Inc offerWeekly Market Report & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
History Review: Is MasterBrand Inc benefiting from interest rate changesPortfolio Growth Summary & Accurate Intraday Trade Tips - baoquankhu1.vn
Is Liminatus Pharma Inc. Equity Warrant subject to activist investor interestTrade Volume Report & Long-Term Investment Growth Plans - mfd.ru
Published on: 2026-02-15 22:28:13 - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant be recession proofTake Profit & Safe Capital Investment Plans - mfd.ru
Why Liminatus Pharma Inc. Equity Warrant stock is recommended by analysts2025 Market Overview & AI Driven Price Predictions - mfd.ru
Bond Watch: Can Xtant Medical Holdings Inc. (XMS) stock withstand sector downturnsJuly 2025 Volume & Long Hold Capital Preservation Tips - mfd.ru
Is WisdomTree Europe Hedged Equity Fund stock among top earnings playsJuly 2025 Price Swings & Comprehensive Market Scan Reports - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant stock maintain growth trajectoryJuly 2025 Update & High Accuracy Trade Signal Alerts - mfd.ru
How do insiders feel about Liminatus Pharma Inc.Quarterly Profit Review & AI Enhanced Trading Signals - mfd.ru
Why Liminatus Pharma Inc. Equity Warrant stock attracts global investorsJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant outperform under higher oil prices2025 Retail Activity & Daily Market Momentum Tracking - mfd.ru
LIMN Liminatus Pharma (NASDAQ) pre-market +15% Feb 12 2026: earnings preview - Meyka
What are Liminatus Pharma Inc.’s recent SEC filings showingWeekly Trend Report & Free Weekly Chart Analysis and Trade Guides - mfd.ru
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Can Liminatus Pharma Inc. Equity Warrant reach resistance levels soon2025 Biggest Moves & Daily Profit Maximizing Tips - mfd.ru
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Highs Report: Is Liminatus Pharma Inc Equity Warrant stock showing strong momentumJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - baoquankhu1.vn
LIMN down 26.83% intraday: Liminatus Pharma (NASDAQ) 09 Feb 2026 earnings ahead - Meyka
Liminatus Pharma Settles Litigation Through Equity Issuance - TipRanks
Liminatus Pharma enters settlement agreement with Clear Street LLC - marketscreener.com
Liminatus Pharma Enters Settlement Agreement With Clear Street LLC - TradingView
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Bond Watch: Will Liminatus Pharma Inc benefit from current market trendsWeekly Trend Report & Detailed Earnings Play Strategies - baoquankhu1.vn
LIMN Liminatus Pharma (NASDAQ) falls 10.24% to $1.84 on 06 Feb 2026: earnings on 12 Feb could reset outlook - Meyka
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
3 Penny Stocks to Watch Now, 2/5/26 - TipRanks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.34% - Investing.com UK
United States shares lower at close of trade; Dow Jones Industrial Average down 0.34% By Investing.com - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.34% - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Top movers analysis one hour before the close of the markets on 2026-02-03: top gainers and losers in today's session. - ChartMill
Liminatus Pharma Inc Stock (LIMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.71%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):